PHIO PHARMACEUTICALS CORP. Stock Issued During Period, Value, Restricted Stock Award, Gross
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, restricted stock award, gross for the quarter ending 2025-09-30 was $0.00.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, restricted stock award, gross for the quarter ending 2024-03-31 was $0.00.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, restricted stock award, gross for the quarter ending 2020-03-31 was -$2.00K.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, restricted stock award, gross for the quarter ending 2019-09-30 was -$3.00K.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, restricted stock award, gross for fiscal 2025 was $0.00.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, restricted stock award, gross for fiscal 2024 was $0.00.
- PHIO PHARMACEUTICALS CORP. stock issued during period, value, restricted stock award, gross for fiscal 2019 was -$3.00K.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Gross 3 month | Stock Issued During Period, Value, Restricted Stock Award, Gross 12 month |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-05 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | |
| 2024-12-31 | $0.00 10-K · filed 2026-03-05 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-11-13 | |
| 2020-03-31 | -$2.00K 10-Q · filed 2020-05-12 | |
| 2019-12-31 | -$3.00K 10-K · filed 2020-03-26 | |
| 2019-09-30 | -$3.00K 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |